primary lung cancer
Conditions
Interventions
Perform stereotactic radiotherapy for primary lung cancer.
Sponsors
Department of Radiology, Nagoya City University Graduate School of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1)Histologically confirmed stage I NSCLC diagnosed according to the 7th TNM classification of lung cancer by the Union for International Cancer Control by chest and upper abdomen CT, brain MRI, and bone scintigraphy or FDG-PET. (2)Greatest tumor diameter <= 5 cm. (3)World Health Organization performance status (PS) <= 2 or PS 3 when its cause was not a pulmonary disease. (4)No prior therapy and no concurrent malignancy. (5)Arterial oxygen pressure >= 60 mmHg, and forced expiratory volume in 1 second >= 700 ml.
Exclusion criteria
Exclusion criteria: (1)No serious diabetes, collagen disease, cardiac disease, pulmonary disease, kidney disease and psychological disorder. (2)Single lung. (3)Receiving home oxygen therapy. (4)Pregnant or lactating woman, likelihood of pregnancy. (5)Active infectious disease. (6)Implanted pacemaker or implantable cardioverter defibrillator. (7)No history of thoracic radiation therapy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| overall survival rate | — |
Secondary
| Measure | Time frame |
|---|---|
| progression-free survival rate, local control rate, adverse event | — |
Countries
Japan
Contacts
Public ContactAkifumi Miyakawa
Nagoya City University Graduate School of Medical Sciences Department of Radiology
Outcome results
None listed